RxDoctor Payments Data

Mark Rittenger

Pulmonary Disease · Grand Blanc, MINPI 1528011004

Payments from drug & device makers

$449in general payments, 2019–2025

Across 28 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$35
  • Boehringer Ingelheim$35
  • Shire North American Group Inc$32
  • Novartis$32
  • Abbott$25
  • Sanofi$24
  • plus $267 from 18 others

What the payments were for

  • Food & beverage$449100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$449 in reported general payments places this provider in the 30th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Other pulmonary disease in Grand Blanc

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →